How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

464

HTML

3259

Figures (1-5)

158

Tables (1-4)

166

Sum=4047

Aug 14, 2011 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3479-3486
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3479

Table 4 Distribution of albumin consumption and cost among the clinical indications for cirrhosis in 2008

	Vials (number)(%)	Cost (euros)	Patients (number)(%)	Vials/patients (number)	Cost/patient (euros)
Ascites	12.540 (63.3)	337.976	453 (56.4)	27.7	746
Paracentesis	4.564 (23.1)	122.988	222 (27.6)	20.6	554
Hepatorenal syndrome	2.340 (11.8)	63.070	106 (13.2)	22.0	595
Spontaneous bacterial peritonitis	367.000 (1.8)	9.880	22 (2.7)	14.0	380

Citation: Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3479.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3479